Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AkNiPro2 nimodipine for hearing preservation in vestibular schwannoma surgery
2024-518182-10-00Phase 3Completed
- Sponsor
- Martin Luther University Halle-Wittenberg
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of nimodipine in acoustic neuroma (2 arms), sponsored by Martin Luther University Halle-Wittenberg. Primary endpoint: Postoperative cochlear nerve function at discharge. Started Oct 2024; status: completed.
02
Drugs
nimodipine
03
Conditions
acoustic neuroma
Beyond the preview
Go deeper on 2024-518182-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518182-10-00.